Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer.

Lu-Yao G, Nikita N, Keith SW, Gandhi K, Shaver AL, Sharma S, Steinbock-Malfer C, Yang H, Yang C, Zarrabi KK, Freedland SJ, Kelly WK

Open source

DOI
10.1093/jnci/djag061
Published
2026 Jul 1
Container
Journal of the National Cancer Institute
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djag061,
  title = {Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer.},
  author = {Lu-Yao G and Nikita N and Keith SW and Gandhi K and Shaver AL and Sharma S and Steinbock-Malfer C and Yang H and Yang C and Zarrabi KK and Freedland SJ and Kelly WK},
  year = {2026},
  journal = {Journal of the National Cancer Institute},
  doi = {10.1093/jnci/djag061},
  url = {https://doi.org/10.1093/jnci/djag061}
}

RIS

TY  - JOUR
TI  - Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer.
AU  - Lu-Yao G
AU  - Nikita N
AU  - Keith SW
AU  - Gandhi K
AU  - Shaver AL
AU  - Sharma S
AU  - Steinbock-Malfer C
AU  - Yang H
AU  - Yang C
AU  - Zarrabi KK
AU  - Freedland SJ
AU  - Kelly WK
PY  - 2026
JO  - Journal of the National Cancer Institute
DO  - 10.1093/jnci/djag061
UR  - https://doi.org/10.1093/jnci/djag061
ER  - 

APA

G, L., N, N., SW, K., K, G., AL, S., S, S., C, S., H, Y., C, Y., KK, Z., SJ, F., & WK, K. (2026). Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer.. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djag061

Source records